CEO SUMMARY: It was record attendance at the major pathology congress which took place in Hangzhou, China, last month. Because of the ongoing growth of China’s economy, the demand for healthcare—and for high-quality clinical lab and pathology testing—is rising at an accelerated pace. During his visit to the pathology congress and Chinese hospital labs, your
Tag: laboratory technology
CEO SUMMARY: Faced with staffing shortages and a ready pool of B.S. graduates in the local community, two years ago, Oregon Medical Laboratories decided to use long-distance learning programs to recruit and train employees interested in earning certification as MTs and MLTs. This business strategy paid off. The first group of students has graduated and
CEO SUMMARY: It was a groundbreaking first for both sides of the Atlantic. Senior pathologists and laboratory directors in the United Kingdom spent two days learning from their North American counterparts about the challenges and difficulties in laboratory consolidation and regionalization. For their part, the North American faculty gained useful insights about the way laboratory
CEO SUMMARY: By law, government regulators cannot comment publicly about the actions they take against the companies they regulate. That’s why the lab industry never learned that other public lab companies operating in California, following inspections by state authorities, were judged to have some deficiencies similar to those found at Specialty Laboratories.
BY NOW, JUST ABOUT
CEO SUMMARY: Rapid changes to the clinical laboratory industry had equally profound impact upon the major diagnostic companies. At Beckman Coulter, Inc., market forces triggered a decade of acquisitions and internal consolidation.The company looks very different today than it did ten years ago. Here’s a look at how Beckman Coulter views the near future for
CEO SUMMARY: During the past five years, powerful forces in the healthcare marketplace positioned hospital-based laboratories to once again become the dominant force in laboratory testing. But this can only occur if today’s generation of hospital laboratory directors and clinical pathologists fully understand this opportunity and act to properly prepare their laboratory. It will require
CEO SUMMARY: CARESIDE’s point-of-care testing system gives laboratory executives a new tool for bringing value-added laboratory services to clinicians. In this exclusive interview, W. Vickery Stoughton, Chairman and CEO of CARESIDE, Inc., shares his perspectives on the clinical laboratory marketplace. As President of SmithKline Beecham Clinical Laboratories, Mr. Stoughton was responsible for starting the effort
CEO SUMMARY: Most laboratorians struggle to get clinicians to pay close attention to the potential for lab data to improve healthcare outcomes. At Northwestern Memorial Hospital, the laboratory acqired in-house molecular typing test capability as one cornerstone for an aggressive infection control program. Physicians, nurses, med techs, pharmacists and even maintenance staff now regularly participate
Automated Cytology Update
As predicted by THE DARK REPORT, the field of automated cytology has become a boiling pot, filled with controversy and change. Profits are meager. As we expected, the major issue revolves around the cost of this enhanced technology versus the measurable clinical benefits it delivers over traditional Pap smear procedures. Here’s a quick
CEO SUMMARY: Nominations are now open as THE DARK REPORT seeks to identify laboratory executives who deserve recognition. Our annual awards program honors the innovators and leaders within the clinical laboratory industry who push the boundaries of management change and show us how to best respond to the challenges of managed healthcare.
WITH 1998 FAST APPROACHING,